UB
ACAD icon

UMB Bank’s Acadia Pharmaceuticals ACAD Stock Holding History

UMB Bank’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.51K Sell
427
-178
-29% -$4.25K ﹤0.01% 1873
2025
Q4 		$16.2K Buy
605
+135
+29% +$3.23K ﹤0.01% 1632
2025
Q3 		$10K Buy
470
+151
+47% +$3.57K ﹤0.01% 1674
2025
Q2 		$6.88K Sell
319
-142
-31% -$2.64K ﹤0.01% 1731
2025
Q1 		$7.66K Buy
+461
New +$8.38K ﹤0.01% 1634
2022
Q2 		– Sell
-794
Closed -$19K – 1891
2022
Q1 		$19K Hold
794
– – ﹤0.01% 1265
2021
Q4 		$18K Buy
+794
New +$16K ﹤0.01% 1300

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return